Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1997 | 12-1996 | 12-1995 | 12-1994 | 12-1993 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,877 | 5,484 | N/A | N/A | N/A |
| Marketable Securities | 61,567 | 25,503 | N/A | N/A | N/A |
| Receivables | 3,683 | 0 | N/A | N/A | N/A |
| Other current assets | 102 | 256 | 0 | 0 | 0 |
| TOTAL | $74,229 | $31,243 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 5,905 | 5,118 | N/A | N/A | N/A |
| Other Non-Current Assets | 0 | 640 | 0 | 0 | 0 |
| TOTAL | $5,905 | $5,758 | $N/A | $N/A | $N/A |
| Total Assets | $80,433 | $37,001 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,227 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 0 | 651 | 0 | 0 | 0 |
| Accrued Expenses | N/A | 3,065 | N/A | N/A | N/A |
| TOTAL | $6,535 | $4,943 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,138 | 2,004 | N/A | N/A | N/A |
| TOTAL | $2,138 | $2,004 | $N/A | $N/A | $N/A |
| Total Liabilities | $8,673 | $6,947 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 168,893 | 51,810 | N/A | N/A | N/A |
| Retained earnings | N/A | -74,082 | N/A | N/A | N/A |
| Other shareholders' equity | -97,133 | 52,326 | 0 | 0 | 0 |
| TOTAL | $71,760 | $30,054 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $80,433 | $37,001 | $0 | $0 | $0 |